Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
10,018 total articles
Cryoport President and CEO Jerrell Shelton sold 7,918 shares on March 16, 2026, for $8.00 each to satisfy tax obligations tied to restricted stock vesting. Shelton retains direct ownership of 1,054,501 shares. The company recently reported Q4 2025 revenue above expectations but posted an EPS shortfall; market metrics show elevated volatility and qu…
Marcelo Cardoso, Executive Vice President and Chief Operating Officer of Laureate Education, sold 7,300 shares on March 17, 2026 under a pre-arranged Rule 10b5-1 plan to cover taxes tied to recently vested performance shares. The transaction totaled $247,542 at $33.91 per share. The company recently reported fourth-quarter 2025 results that beat re…
Edward J. Zecchini, Cryoport's Chief Digital and Technology Officer, sold 2,014 shares on March 16, 2026, and on March 14 reported receipt of restricted stock rights and stock options. The company’s shares trade modestly above the sale price but are flagged by InvestingPro as overvalued; Q4 2025 results showed a revenue beat and an EPS shortfall, w…
Laura Miele, President of EA Entertainment, sold 2,500 shares of Electronic Arts Inc. on March 16, 2026, bringing proceeds of roughly $499,883. The transaction occurred under a 10b5-1 plan established August 8, 2025, and leaves Miele with 45,843 shares. The sale happened while EA shares traded near $200.12, close to a 52-week high. The company repo…
Jorey Chernett, who holds roughly 10% of Oncology Institute, Inc., purchased $1,225,100 worth of common stock across three trading days in mid-March 2026, according to a Form 4 filing. The insider buys coincided with a recent earnings beat and follow strong one-year price appreciation for TOI shares.
Caroline Stockdale, First Solar's Chief People and Communications Officer, disposed of 335 shares on March 16 for $67,268. The transaction reduced her direct stake as the company navigates a Q4 2025 earnings shortfall and 2026 revenue guidance below Street expectations, prompting multiple analyst target cuts and rating adjustments.
Mirum Pharmaceuticals Chief Financial Officer Eric Bjerkholt sold 7,287 shares on March 16, 2026 to satisfy tax withholding tied to vested performance restricted stock units, after exercising options on 13,334 shares a day earlier. The company's stock has risen sharply over the past year even as some valuation models rank it among the most overvalu…
Peter Radovich, Mirum Pharmaceuticals' President and COO, sold 16,515 shares on March 16, 2026, for roughly $1.5 million after exercising options the day before to acquire 30,220 shares. The company reported strong Livmarli sales in Q4 2025, maintained fiscal 2026 sales guidance, and completed enrollment or screening milestones in several Phase 3 t…
Mirum Pharmaceuticals Chief Medical Officer Joanne Quan sold 7,287 shares on March 16, 2026 to satisfy tax-withholding obligations tied to the vesting of performance restricted stock units (PRSUs). Quan had exercised 13,334 PRSUs the previous day. The company has reported several Phase 3 enrollment completions and reiterated sales guidance for fisc…
Jolanda Howe, Senior Vice President and Global Controller at Mirum Pharmaceuticals, sold 4,732 shares on March 16, 2026, for $435,239 and converted several performance restricted stock units a day earlier. The transactions leave her with 8,429 shares. The moves arrive as MIRM shares have climbed materially over the past year and the company reports…
First Solar Chief Manufacturing Officer Kuntal Kumar Verma sold 572 shares of company stock March 16-17, 2026 under a pre-arranged 10b5-1 trading plan for a total of $78,713. Verma also received 907 shares on March 13 when restricted stock units vested. The insider activity comes as multiple analysts downgrade the stock or trim price targets after …
Nathan B. Theurer, First Solar's vice president and global controller, sold 131 shares of common stock in mid-March for a combined total of $7,028. The transactions coincided with the vesting and conversion of 131 restricted stock units. The stock has risen more than 50% over the last year but is down 23% year-to-date. The company’s recent fourth-q…
Stephen F. Page, a director at AeroVironment Inc (NASDAQ: AVAV), sold 250 shares on March 16, 2026 for $21,252 per share, netting $53,130. The transaction was conducted under a Rule 10b5-1 plan established by the Stephen F. Page Living Trust. The company recently reported third-quarter revenue of $408 million and adjusted EBITDA of $44.5 million, a…
First Solar Inc.'s General Counsel and Secretary, Jason E. Dymbort, sold 9,380 shares of company stock on March 16 and 17, 2026, for roughly $1.8 million, according to a Form 4 filing. The filings also show a prior vesting of restricted stock units and leave Dymbort with 9,850 shares. The insider sale occurs against a backdrop of mixed fourth-quart…
Patrick James Buehler, Chief Product Officer at First Solar, sold 180 shares on March 16 for $200.8 per share, netting $36,144. Earlier, on March 13, he received 427 shares from vested restricted stock units. The company’s stock remains up roughly 51% over the past year, trades near $200, and is assessed by InvestingPro as potentially undervalued w…
Director Wood Daniel S sold 20,000 shares of Consumer Portfolio Services, Inc. (NASDAQ: CPSS) on March 13, 2026, for $7.53 per share, a transaction valued at $150,600. Following the sale the director retains 194,943 shares. The company's fourth-quarter 2025 results missed analyst expectations on both earnings and revenue, and the stock has since tr…
Liveperson NASDAQ:LPSN finance chief and chief operating officer John DeNeen Collins completed an automatic sale of 931 shares on March 17, 2026, to satisfy tax liabilities arising from the vesting and settlement of performance-based restricted stock units. The sale, executed at $2.72 per share for a total of $2,532, occurred while the stock traded…
LivePerson Inc. CEO Anthony John Sabino had 12,594 shares of common stock sold on March 17, 2026, in an automated transaction to satisfy tax obligations tied to the vesting of restricted stock units. The sale generated $34,255 at $2.72 per share as the stock trades close to its 52-week low and after the company reported mixed fourth-quarter 2025 re…
Monica L. Greenberg, Executive Vice President at LivePerson Inc., sold 315 shares of company stock on March 17, 2026, in an automatic transaction to satisfy tax obligations tied to the vesting and settlement of performance-based restricted stock units. The sale, recorded on a Form 4 filing with the SEC, totaled $856. The company recently reported a…
Curbline Properties Corp. President and CEO David R. Lukes sold 123,412 shares of common stock across transactions on March 13 and March 16, 2026, generating roughly $3.3 million. The disposals came while the stock traded near its 52-week high and after a recent spate of corporate activity including a $111.4 million acquisition of convenience shopp…
Todd Glickman, Senior Vice President, Chief Financial Officer and Treasurer of Navitas Semiconductor Corp (NASDAQ: NVTS), sold 98,152 shares of Class A common stock on March 17, 2026, at $10.78 per share for proceeds of approximately $1.06 million. The transaction was carried out to satisfy tax withholding tied to the vesting of a compensatory awar…
Astera Labs director Jack R. Lazar sold 2,500 shares on March 16, 2026, for $130.00 per share, totaling $325,000. The transaction was carried out automatically under a Rule 10b5-1 plan adopted December 2, 2025. The sale occurred while Astera Labs shares were trading at $127.56, well below their 52-week high but up year-over-year. Separately, the co…
GeneDx Holdings Corp. Chief Executive Officer Katherine Stueland sold 17,179 shares of Class A Common Stock on March 16, 2026, raising about $1.32 million. The transactions were executed to satisfy tax withholding related to RSU vesting and were not discretionary. The company reported mixed fourth-quarter results and faces new competition in whole …
PACS Group, Inc. President and COO Joshua Jergensen sold 36,335 shares on March 13, 2026, in a transaction valued at $1.24 million, according to a Form 4 filed with the SEC. The move comes while PACS stock trades at $35.7 after a 191% one-year gain and a market capitalization of $5.51 billion. The company reported solid fourth-quarter 2025 results …
GeneDx Holdings Corp CFO Kevin Feeley sold 5,706 shares of Class A common stock on March 16, 2026, for roughly $438,202 after exercising options to acquire 11,012 shares with a zero exercise price. The transactions leave Feeley with direct ownership of 27,148 shares and additional potential holdings through RSUs and options. The stock has recently …
